AI assistant
Sending…
BOSTON SCIENTIFIC CORP — Director's Dealing 2013
Feb 20, 2013
29821_dirs_2013-02-20_27473fc8-d074-4157-9250-6ee294598615.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-02-16
Reporting Person: Pucel Kenneth (EVP, Glob Ops, Qual & Tech)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-16 | Common Stock | M | 6748.0000 | $0.0000 | Acquired | 116874.0000 | Direct |
| 2013-02-16 | Common Stock | F | 2207.0000 | $7.5400 | Disposed | 114667.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-16 | Deferred Stock Units | $ | M | 6748.0000 | Disposed | Common Stock (6748.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan.
F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
F4: Reflects multiple DSU awards with independent vesting schedules.
More from BOSTON SCIENTIFIC CORP
Regulatory Filings
2026
May 21
Transaction in Own Shares
2026
May 18
Capital/Financing Update
2026
May 18
Share Issue/Capital Change
2026
May 8
Major Shareholding Notification
2026
May 6
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Interim / Quarterly Report
2026
May 1
Major Shareholding Notification
2026
Apr 29
Earnings Release
2026
Apr 22
Regulatory Filings
2026
Apr 2